Все публикации

0:01:13

Impact of national screening program on the elective AAA repair rate & RAAA incidence in population

0:00:43

CX Aortic Vienna: Advance registration ends in 1 week!

0:01:57

Introduction to CX Aortic Vienna 2022

0:07:46

Shape Memory Polymer addresses an “unmet need” for EVAR

0:04:43

APDVS president reflects on COVID-19 training challenges, supply and demand conundrum of the future

0:03:09

Disruptive technology and high-quality clinical evidence: An Endologix transformation

0:05:16

Shockwave IVL: Maintaining options for patients with calcified PAD

0:04:16

Shockwave IVL: Seeing is believing

0:03:26

CX 2022: Choose to attend in-person or virtually

0:01:27

CX 2022: Nick Inston on Vascular Access Challenge

0:02:24

CX 2022: Haulon, Mastracci and Kölbel on Aortic Challenges

0:01:27

CX Aortic Vienna 2021: Watch the key pivotal discussions on-demand! Day 2 Highlights

0:03:26

Future training of aortic surgeons with Dr Eric Roselli

0:04:24

The balance of open and endovascularaortic care with Dr Gustavo Oderich

0:03:09

Edited Cases and the Latest Technology Showcased at CX Aortic Vienna 2021

0:02:34

CX Aortic Vienna 2021: A Conversation with Dr. Joseph Coselli

0:01:15

CX Aortic Vienna 2021 - What To Expect

0:03:05

Vascular Trauma Controversies at CX 2021

0:02:15

The Hurting Leg session: 'Unacceptably high' major amputation rates and the effects of COVID

0:05:26

Lively debates will tackle the biggest controversies in Abdominal Aortic session

0:02:53

Paclitaxel controversy and Podium 1st presentations take centre stage in Peripheral session

0:41:27

COVID-19 and how it affects the global vascular community

0:10:44

CX 2019: Statistical review of methodology and legitimacy of results

0:08:22

Patient-level data from the IN.PACT Clinical Programme: Is paclitaxel safe for treatment of PAD?